1. Home
  2. HALO vs AM Comparison

HALO vs AM Comparison

Compare HALO & AM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • AM
  • Stock Information
  • Founded
  • HALO 1998
  • AM 2013
  • Country
  • HALO United States
  • AM United States
  • Employees
  • HALO N/A
  • AM N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • AM Natural Gas Distribution
  • Sector
  • HALO Health Care
  • AM Utilities
  • Exchange
  • HALO Nasdaq
  • AM Nasdaq
  • Market Cap
  • HALO 7.6B
  • AM 8.5B
  • IPO Year
  • HALO N/A
  • AM 2014
  • Fundamental
  • Price
  • HALO $73.13
  • AM $17.90
  • Analyst Decision
  • HALO Buy
  • AM Hold
  • Analyst Count
  • HALO 12
  • AM 3
  • Target Price
  • HALO $73.33
  • AM $18.83
  • AVG Volume (30 Days)
  • HALO 2.7M
  • AM 2.7M
  • Earning Date
  • HALO 11-03-2025
  • AM 10-29-2025
  • Dividend Yield
  • HALO N/A
  • AM 5.06%
  • EPS Growth
  • HALO 56.68
  • AM 20.98
  • EPS
  • HALO 4.74
  • AM 0.98
  • Revenue
  • HALO $1,242,852,000.00
  • AM $1,249,571,000.00
  • Revenue This Year
  • HALO $32.47
  • AM $4.60
  • Revenue Next Year
  • HALO $24.31
  • AM $3.09
  • P/E Ratio
  • HALO $15.34
  • AM $18.16
  • Revenue Growth
  • HALO 31.19
  • AM 8.70
  • 52 Week Low
  • HALO $46.26
  • AM $14.22
  • 52 Week High
  • HALO $79.50
  • AM $19.82
  • Technical
  • Relative Strength Index (RSI)
  • HALO 63.53
  • AM 50.83
  • Support Level
  • HALO $68.09
  • AM $17.45
  • Resistance Level
  • HALO $70.81
  • AM $18.21
  • Average True Range (ATR)
  • HALO 2.26
  • AM 0.35
  • MACD
  • HALO 0.46
  • AM 0.03
  • Stochastic Oscillator
  • HALO 80.82
  • AM 65.57

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.

Share on Social Networks: